Tech Company Financing Transactions
Celltrio Funding Round
Celltrio closed a $15 million financing round on 6/17/2025. Investors included Premier Partners and private investors.
Transaction Overview
Company Name
Announced On
6/17/2025
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Premier Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the global commercialization of RoboCell, its flagship modular platform for fully automated, sterile cell culturing and cell therapy manufacturing.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
47777 Warm Springs Boulevard
Fremont, CA 94539
USA
Fremont, CA 94539
USA
Phone
Undisclosed
Website
Email Address
Overview
Celltrio is leading the world of lab automation through its modular integration of proven task modules, data management software, and robotics. We manufacture robotic-based solutions for the life sciences industry with unique, patented, or patent-pending intellectual property (IP) protected solutions in biobanking, cell culturing automation, and more. Our solutions are based on IP (including 10 patents) acquired for global exclusivity from our Korean partner who has manufactured and installed over 5000 robots and 11,000 linear modules for the Life Sciences and Semiconductor markets. We are bringing proven solutions to the world market, and expanding the technology and product line with our US-based engineering team.
Management Team
Browse more venture capital transactions:
Prev: 6/17/2025: Zoot venture capital transaction
Next: 6/17/2025: Prop-AI venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs